Technical innovation of Ervin G Erdös: A mechanical transducer for isotonic muscle contractions

Q4 Medicine Scripta Medica Pub Date : 2022-01-01 DOI:10.5937/scriptamed53-36101
R. Igić
{"title":"Technical innovation of Ervin G Erdös: A mechanical transducer for isotonic muscle contractions","authors":"R. Igić","doi":"10.5937/scriptamed53-36101","DOIUrl":null,"url":null,"abstract":"Let me explain the principle of bioassay. It is an analytical method for determination of the relative strength (concentration or potency) of a substance by comparing its effect on a test organism (living animal, cells or tissues) with that of a standard preparation. Bioassays are used in pharmacology mainly to determine the concentrations of hormones or drugs, eg biologically active peptides, acetylcholine, catecholamines, prostaglandins, histamine and prostacyclin. However, there are other forms of bioassay in which one can use isolated tissues and determine actions of their nerves, such as the nerve to the diaphragm from rats. Bioassays may also be done in vivo in individual humans. The assessment of drug effects in humans is designated by clinical pharmacologists as a clinical trial. Such trials often require hundreds or sometimes thousands of patients in order to test efficacy and safety of any new drug before it can be marketed. If the human investigations produce unexpected results, quite different of those obtained in the animal experiments the trials must be redesigned, to examine why and how this occurred. There are many examples of how such discoveries resulted in new clinically useful medications (eg, discovery antihypertensive effect of beta-adrenergic blocking agents).6 Accordingly, the pharmacologists have the bioassays, as a tool, which help them in the discovery process. I wrote on the renowned pharmacologist Professor Ervin G Erdös and his scientific opus in my reminiscence article written on the occasion of his death in 2019.1 When I attended the Fourth International Congress in Pharmacology in Basel in 1969, Dr Ervin G Erdös invited me to join his laboratory. Thus, in April 1970, I arrived in Oklahoma City as a Fulbright Fellow to work with him for two years. Later on, as a visiting scientist I frequently worked in his research laboratories in Dallas and Chicago and we shared research interests through visits across the Atlantic between the former Yugoslavia and the United States.2, 3","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scripta Medica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5937/scriptamed53-36101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Let me explain the principle of bioassay. It is an analytical method for determination of the relative strength (concentration or potency) of a substance by comparing its effect on a test organism (living animal, cells or tissues) with that of a standard preparation. Bioassays are used in pharmacology mainly to determine the concentrations of hormones or drugs, eg biologically active peptides, acetylcholine, catecholamines, prostaglandins, histamine and prostacyclin. However, there are other forms of bioassay in which one can use isolated tissues and determine actions of their nerves, such as the nerve to the diaphragm from rats. Bioassays may also be done in vivo in individual humans. The assessment of drug effects in humans is designated by clinical pharmacologists as a clinical trial. Such trials often require hundreds or sometimes thousands of patients in order to test efficacy and safety of any new drug before it can be marketed. If the human investigations produce unexpected results, quite different of those obtained in the animal experiments the trials must be redesigned, to examine why and how this occurred. There are many examples of how such discoveries resulted in new clinically useful medications (eg, discovery antihypertensive effect of beta-adrenergic blocking agents).6 Accordingly, the pharmacologists have the bioassays, as a tool, which help them in the discovery process. I wrote on the renowned pharmacologist Professor Ervin G Erdös and his scientific opus in my reminiscence article written on the occasion of his death in 2019.1 When I attended the Fourth International Congress in Pharmacology in Basel in 1969, Dr Ervin G Erdös invited me to join his laboratory. Thus, in April 1970, I arrived in Oklahoma City as a Fulbright Fellow to work with him for two years. Later on, as a visiting scientist I frequently worked in his research laboratories in Dallas and Chicago and we shared research interests through visits across the Atlantic between the former Yugoslavia and the United States.2, 3
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Ervin G的技术革新Erdös:一种等张力肌肉收缩的机械换能器
让我来解释一下生物测定法的原理。这是一种通过比较其对被试生物(活的动物、细胞或组织)与标准制剂的作用来测定物质相对强度(浓度或效价)的分析方法。生物测定法在药理学中主要用于测定激素或药物的浓度,如生物活性肽、乙酰胆碱、儿茶酚胺、前列腺素、组胺和前列环素。然而,还有其他形式的生物测定,其中人们可以使用分离的组织并确定其神经的作用,例如来自大鼠的横膈膜神经。生物测定也可在人体内进行。临床药理学家将药物对人体的作用评估称为临床试验。这种试验通常需要数百甚至数千名患者,以便在任何新药上市之前测试其有效性和安全性。如果人体研究产生了意想不到的结果,与动物实验中获得的结果完全不同,则必须重新设计试验,以检查这种情况发生的原因和方式。有许多这样的发现如何导致新的临床有用药物的例子(例如,发现-肾上腺素能阻滞剂的降压作用)因此,药理学家有生物测定作为一种工具,这有助于他们在发现过程中。我于2019年在著名药理学家Ervin G教授去世之际写了一篇关于他的文章Erdös和他的科学著作19.1 1969年我参加在巴塞尔举行的第四届国际药理学大会时,Ervin G博士Erdös邀请我加入他的实验室。因此,1970年4月,我以富布赖特研究员的身份来到俄克拉荷马城,和他一起工作了两年。后来,作为一名访问科学家,我经常在他位于达拉斯和芝加哥的研究实验室工作,并通过在前南斯拉夫和美国之间跨越大西洋的访问,我们分享了研究兴趣
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.60
自引率
0.00%
发文量
13
审稿时长
4 weeks
期刊最新文献
Outcome of vacuum assisted dressing in open comminuted tibial fracture with primary fixation Assessment of adverse drug reactions in oral cancer patients receiving chemotherapy treatment at tertiary care centres in North-Western India Occupational diseases in the Republic of Srpska from 2011-2020 Spontaneous closure of isolated Ventricular septal defect in the first year A pilot test for implementing precision healthcare programme in patients with diabetes in Indonesia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1